Comparison of pharmacokinetics of danofloxacin and enrofloxacin in calves challenged with Mannheimia haemolytica

Abstract

When used to treat pneumonic pasteurellosis in calves, danofloxacin and enrofloxacin can be expected to deliver concentration-dependent bactericidal activity against M. haemolytica, the bacteria most commonly associated with bovine respiratory tract disease.

References

Page 1

	Year	Citations
Antimicrobial Therapy in Veterinary Medicine Journal of Equine Veterinary Science AntibioticsVeterinary ScienceVeterinary MicrobiologyAntimicrobial TherapyAntimicrobial Agents	2001	844
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance J. Blaser, Benjamin B. Stone, Moritz Gröner, Antimicrobial Agents and Chemotherapy Escherichia ColiPeak ConcentrationAntimicrobial ChemotherapyVitro Pharmacokinetic ModelAntibiotic Resistance	1987	484
The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Paul M. Vancutsem, John G. Babish, Wayne S. Schwark PubMed Large VolumeAntimicrobial ChemotherapyAdverse EffectsToxicologyAntimicrobial Therapy	1990	204
Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones P. C. T. HANNAN, G.D. Windsor, Anno de Jong, Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityHealth SciencesMycoplasma StrainsMedicineEquivalent Activities	1997	156
Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows Liisa Kaartinen, Marja Salonen, L. ÄLLI, Journal of Veterinary Pharmacology and Therapeutics Animal PhysiologySubcutaneous InjectionsAnimal ScienceMedicineBioanalysis	1995	149
Pharmacokinetics of Enrofloxacin and Danofloxacin in Plasma, Inflammatory Exudate, and Bronchial Secretions of Calves following Subcutaneous Administration Quintin McKellar, Ian F. Gibson, Ana Monteiro, Antimicrobial Agents and Chemotherapy	1999	107
Can PK/PD be used in everyday clinical practice Francesco Scaglione International Journal of Antimicrobial Agents Primary CareClinical EffectivenessPatient SafetyEvidence-based MedicineLaboratory Medicine	2002	89
Clinical pharmacokinetics of parenterally administered danofloxacin in cattle C. Giles, R. A. Magonigle, W. T. R. Grimshaw, Journal of Veterinary Pharmacology and Therapeutics	1991	70
Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections J Meinen, J. Trenton McClure, Eberhard Rosin American Journal of Veterinary Research	1995	69
Pharmacokinetic–pharmacodynamic integration of danofloxacin in the calf F. Shojaee Aliabadi, P. Lees Research in Veterinary Science Animal PhysiologyVeterinary PhysiologyAnimal ScienceMedicinePhysiology	2003	63

Page 1